A5011318905- Central Venous Catheters and Hemodialysis
- Dialysis and Renal Disease Management
- Vascular Procedures and Complications
- Peripheral Artery Disease Management
- Cardiac Arrhythmias and Treatments
- Atrial Fibrillation Management and Outcomes
- Erythropoietin and Anemia Treatment
- Muscle and Compartmental Disorders
- Antibiotics Pharmacokinetics and Efficacy
- Renal Diseases and Glomerulopathies
- Pharmacological Effects and Toxicity Studies
- Vascular anomalies and interventions
- Acute Kidney Injury Research
- Iterative Methods for Nonlinear Equations
- Patient Satisfaction in Healthcare
- Hepatitis C virus research
- Historical Art and Architecture Studies
- Matrix Theory and Algorithms
- Historical Studies of Medieval Iberia
- Electrolyte and hormonal disorders
- Vasculitis and related conditions
- Patient Safety and Medication Errors
- Health Services Management and Policy
- Diagnosis and Treatment of Venous Diseases
- Clinical Laboratory Practices and Quality Control
Hospital Universitario del Henares
2014-2024
BMJ Group (United Kingdom)
2018
Universidad de Alcalá
2002
El acceso vascular para hemodiálisis es esencial el enfermo renal tanto por su morbimortalidad asociada como repercusión en la calidad de vida. proceso que va desde creación y mantenimiento del hasta tratamiento sus complicaciones constituye un reto toma decisiones debido a complejidad patología existente diversidad especialidades involucradas. Con fin conseguir abordaje consensuado, Grupo Español Multidisciplinar Acceso Vascular (GEMAV), incluye expertos las cinco sociedades científicas...
Vascular access for haemodialysis is key in renal patients both due to its associated morbidity and mortality impact on quality of life. The process, from the creation maintenance vascular treatment complications, represents a challenge decision-making, because complexity existing disease diversity specialities involved. With view finding common approach, Spanish Multidisciplinary Group Access (GEMAV), which includes experts five scientific societies involved (nephrology [S.E.N.], surgery...
La aplicación de una solución antiséptica previa al uso los catéteres tunelizados es práctica recomendada. Estas medidas habituales en la manipulación para hemodiálisis son cruciales evitar complicaciones. Presentamos un brote infección por Serratia marcescens (S. marcescens) varias unidades Comunidad Autónoma Madrid. Los primeros casos bacteriemia S. fueron aislados diciembre 2014. detección germen infrecuente varios pacientes se puso conocimiento Servicios Medicina Preventiva sospecha...
The application of antiseptic solution for handling tunnelled catheters is recommended in patients undergoing haemodialysis. These routine procedures are crucial to avoid complications. We report an outbreak Serratia marcescens (S. marcescens) bacteraemia numerous haemodialysis units the Community Madrid. first cases due S. were isolated December 2014. Preventive Medicine Services informed detection atypical pathogen several patients, suspecting a probable nosocomial outbreak. Information...
The interest in the preservation of residual kidney function on starting renal replacement therapy (RRT) is very common techniques such as peritoneal dialysis but less so haemodialysis (HD). In our centre pattern incremental (2 HD/week) has been an option for a group patients. Here we share experience with this regimen from March 2008.We included incident patients diuresis >1,000ml/24h, clinical stability, absence oedema, hyperkalaemia >6.5 mEq/l and phosphoremia >6mg/dl, acceptable...
Abstract Background Thrice-weekly haemodialysis is the usual dose when starting renal replacement therapy; however, this schedule no longer appropriate since it does not consider residual function. Several reports have suggested potential benefit of beginning less frequently and incrementally increasing as function decreases. However, all data published so far are from observational studies. Thus, clinical trial avoids any selection bias will assess possible benefits that been observed in...
Pauci-immune vasculitis is a heterogeneous disorder with an unfavourable prognosis. Renal involvement frequently observed in antineutrophil cytoplasm autoantibody (ANCA)-associated small-vessel and important cause of end-stage renal disease (ESRD). replacement therapy (RRT) required. Although better prognosis under dialysis well known, the long-term follow-up pauci-immune RRT rarely reported.We described 24 patients requirement who were admitted our institutions from January 1989 to December...
Abstract Vitamin D deficiency is common in dialysis patients with chronic kidney disease. Low levels have been associated increased cardiovascular risk and mortality. We evaluated the administration of a high, single oral dose 25‐ OH cholecalciferol (3 mg H idroferol, 180 000 IU ) on hemodialysis. The 94 hemodialysis vitamin 25 ( <30 ng/mL included study were randomized into two groups. Follow‐up time was 16 weeks. Neither usual treatment for controlling C a/ P nor bath (calcium 2.5...
Background: Many patients with newly created arteriovenous fistulas (AVF) may die before the AVF is needed for hemodialysis. However, formal competing risks frameworks are rarely used to report patency, which lead biased estimates. We sought identify proportion of experiencing primary non-function and describe long-term patency using a risk framework. Methods: did prospective observational study in 257 adults Alberta, Canada. The outcome was non-function. Secondary outcomes included loss...
Improving healthcare means challenging the status quo.This week The BMJ offers a range of ways to do that.